Neonatal Respiratory Distress Syndrome: CUROSURF® (poractant alfa) Overview

Please see full ISI below, at the end of the above video, and on the website: https://curosurf.com/ Learn more about the experience CUROSURF can offer in treating your infants with Respiratory Distress Syndrome (RDS). See the mechanism of action (MOA), efficacy, dosing administration guidelines and more. IMPORTANT SAFETY INFORMATION CUROSURF® (poractant alfa) is intended for intratracheal use only. The administration of exogenous surfactants, including CUROSURF, can rapidly affect oxygenation and lung

• #فناوری_و_رایانه
• #ldquoneonatal_respiratory_distress_syndromerdquo
• #ldquordsrdquo
• #ldquorespiratory_distress_syndromerdquo